Edward Wilkinson, MD

Professor and Vice-Chairman
Director, Cytopathology Fellowship
Medical Director, Quantitative Pathology Laboratory, UFDRL
Adjunct Professor, Department of Obstetrics and Gynecology

Dept. of Pathology, Immunology and Laboratory Medicine
University of Florida, College of Medicine
P.O. Box 100275
Gainesville, FL 32610-0275

Office Location and Express Mail address:
Dept. of Pathology, Immunology and Laboratory Medicine
University of Florida College of Medicine
JHMHSC 3257.5
1600 SW Archer Rd
Gainesville, FL 32610-0275

Office: (352) 265-0208 x4-4962
Fax: (352) 265-0437

Office Manager: Karen Hyde 265-0238 x4-4949

Email: wilkinso@pathology.ufl.edu

Currently Involved In:

Edward J. Wilkinson, MD is Professor and Vice Chairman in the Department of Pathology at the University of Florida College of Medicine, where he also directs the Cytopathology Fellowship program and is the Medical Director of the Department's Quantitative Pathology Laboratory. As prior president of the American Society for Colposcopy and Cervical Pathology he initiated the first Consensus Conference on the Management of Women with Abnormal Cervical Cytology in 2001, and served as the Chairman of the Steering Committee and Chair of the LSIL committee directing this evidence based conference. For the second 2006 ASCCP Consensus Conference he served on the Steering Committee and as Chairman of the Human Papillomavirus Testing Committee. Dr. Wilkinson is also a past President of the International Society for the Study of Vulvovaginal Disease and the Florida Society of Pathologists. He is Editor-in-Chief of the Journal of Lower Genital Tract Disease, and serves as a member of the editorial boards of the journals Human Pathology, International Journal of Gynecological Pathology, The Breast Journal, and The Journal of Gynecological Surgery. He also serves as a special reviewer for several other leading medical journals. He is listed in Who's Who in Medicine and Health, Who's Who in the World, and is in the Best Doctors in America,(gynecological pathology) being listed in the first, and all subsequent publications for the past 15 years. In a career spanning more than forty years, he has researched and published on cancers and pre-neoplastic lesions of the cervix, vulva, vagina, endometrium, ovary and breast. He has been awarded funding from the National Cancer Institute and the American Cancer Society, and served as a member of the Data and Safety Monitoring Committee of NCI's ALTS trial.

Notable scientific contributions include: first to directly measure and to quantitate alpha fetoprotein in ovarian endodermal sinus tumor. First to document, through retrospective sectioning and detailed analysis of 525 Stage 1 breast carcinoma cases initially interpreted as having negative lymph nodes, that occult micro metastasis can be detected and occur in over 15% of cases and that these micrometastaisis do not significantly decrease survival as compared to cases with negative lymph nodes. First to develop a mathematical model to estimate probabilities of missing micrometastasis in lymph nodes by histopathologic study when using various sectioning intervals. Pioneered in defining a subset of minimally invasive vulvar carcinomas as carrying essentially no risk for lymph node metastases. Instrumental in working with the ISSVD, the International Society of Gynecological Pathologists, and F.I.G.O. in establishing Stage IA vulvar carcinoma as a tumor stage, and a stage of tumor that can be managed by less than radical surgery. First to describe and define endometrial well differentiated papillary adenocarcinoma (subsequently called villo-glandular adenocarcinoma) and distinguish this tumor as having a relatively good prognosis as compared to papillary serous adenocarcinoma. First to report and document, with family linkage, congenital cirrhosis in the newborn due to S-Z phenotype alpha-1-antitrypisin deficiency. First to define and document acquired columnar cell metaplasia of the squamous mucosa of the vagina. Developed the first comprehensive etiologic classification of vulvar Paget disease based on histopathologic, immunohistochemical and clinical features. (See: E.J. Wilkinson in faculty in web site: www.pathology.ufl.edu)

Curriculum Vitae

Publications

Primary Navigation